NASDAQ:DRRX
Durect Corporation Stock News
$0.91
+0.0320 (+3.64%)
At Close: Apr 18, 2024
Durect (DRRX) Reports Q4 Loss, Misses Revenue Estimates
06:10pm, Wednesday, 27'th Mar 2024
Durect (DRRX) came out with a quarterly loss of $0.27 per share versus the Zacks Consensus Estimate of a loss of $0.36. This compares to loss of $0.46 per share a year ago.
Top 3 Health Care Stocks That Are Preparing To Pump This Month - Durect (NASDAQ:DRRX), Aadi Bioscience (NASDAQ:AADI)
07:39am, Monday, 18'th Dec 2023
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
DURECT Corporation (DRRX) Q3 2023 Earnings Call Transcript
06:50pm, Monday, 13'th Nov 2023
DURECT Corporation (NASDAQ:DRRX ) Q3 2023 Earnings Conference Call November 13, 2023 4:30 PM ET Company Participants Tim Papp - Chief Financial Officer Jim Brown - Chief Executive Officer Conference C
Why Is Durect (DRRX) Stock Down 64% Today?
08:40am, Wednesday, 08'th Nov 2023
Durect (NASDAQ: DRRX ) stock is falling hard on Wednesday after the late-stage biopharmaceutical company released results from a Phase 2b clinical trial. This clinical trial covered the efficiency of
3 Promising Biotech Stocks That Will Make Early Investors Rich
03:07pm, Monday, 02'nd Oct 2023
For investment ideas that can potentially lead to life-changing gains, few sectors are as viable as biotech stocks to make you rich. Fundamentally, the biotechnology sector offers potential therapeuti
DURECT Corporation Announces Presentations in Upcoming Investor Conferences
04:30pm, Thursday, 31'st Aug 2023
CUPERTINO, Calif. , Aug. 31, 2023 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX), a biopharmaceutical company committed to transforming the treatment of acute organ injury and chronic liver disease
DURECT Corporation (DRRX) Q2 2023 Earnings Call Transcript
08:22pm, Wednesday, 09'th Aug 2023
DURECT Corporation (NASDAQ:DRRX ) Q2 2023 Earnings Conference Call August 9, 2023 4:30 PM ET Company Participants Timothy Papp - CFO & Secretary James Brown - Co-Founder, CEO, President & Director Wei
DURECT Corporation (DRRX) Q1 2023 Earnings Call Transcript
10:42pm, Monday, 08'th May 2023
DURECT Corporation (NASDAQ:DRRX ) Q1 2023 Earnings Conference Call May 8, 2023 4:30 PM ET Company Participants Tim Papp - Chief Financial Officer Jim Brown - Chief Executive Officer Keith Lui - Senior
Durect (DRRX) Reports Q1 Loss, Misses Revenue Estimates
07:02pm, Monday, 08'th May 2023
Durect (DRRX) came out with a quarterly loss of $0.52 per share versus the Zacks Consensus Estimate of a loss of $0.50. This compares to loss of $0.50 per share a year ago.
DURECT Corporation to Announce First Quarter 2023 Financial Results and Provide Business Update on May 8
07:03pm, Monday, 01'st May 2023
CUPERTINO, Calif. , May 1, 2023 /PRNewswire/ --- DURECT Corporation (Nasdaq: DRRX) today announced that it will report its first quarter 2023 financial results and host a conference call after the mar
DURECT Corporation to Participate in Fireside Chat at the H.C. Wainwright BioConnect Investor Conference
06:45pm, Tuesday, 25'th Apr 2023
CUPERTINO, Calif. , April 25, 2023 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) today announced that Dr. James Brown, President and CEO, will participate in a fireside chat hosted by Ed Arce, Man
Benzinga's Top Ratings Upgrades, Downgrades For March 14, 2023
03:00pm, Tuesday, 14'th Mar 2023 Benzinga
Upgrades
Citigroup upgraded the previous rating for LexinFintech Holdings Ltd (NASDAQ:LX) from Neutral to Buy. In the fourth quarter, LexinFintech Holdings showed an EPS of $0.30, compared to $0.24 fr
Tesla To Rally More Than 12%? Here Are 10 Other Analyst Forecasts For Wednesday
12:59pm, Wednesday, 08'th Mar 2023 Benzinga
HC Wainwright & Co. cut the price target for DURECT Corporation (NASDAQ: DRRX) from $35 to $32. HC Wainwright & Co. analyst Ed Arce maintained a Buy rating. DURECT shares fell 1.3% to close at $4.75
Durect (DRRX) Reports Q4 Loss, Tops Revenue Estimates
10:35pm, Tuesday, 07'th Mar 2023 Zacks Investment Research
Durect (DRRX) delivered earnings and revenue surprises of 13.21% and 2.79%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Durect (DRRX) Reports Q4 Loss, Tops Revenue Estimates
06:48pm, Tuesday, 07'th Mar 2023
Durect (DRRX) delivered earnings and revenue surprises of 13.21% and 2.79%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?